ArticleAvicenna journal of medical biotechnology

Recombinant Production of TP4-LYC1, A New Chimeric Peptide with Targeted Cytotoxicity to HeLa Cells.

Hanieh Mohammad Pour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.